What Makes IVF-PGT Technology in the USA Special?

2024-10-08 20:09:22，visits： 52

The development of IVF technology has continuously evolved with advancements in science and technology, and we have now entered the era of IVF-PGT. Compared to the first and second generations of IVF, this technology not only achieves higher accuracy in embryo cultivation and screening, but also offers more options for older women and families with special needs.

The core of IVF-PGT lies in two critical steps: first, cultivating the embryo to the blastocyst stage, and second, conducting chromosomal and genetic analysis on each blastocyst. Dr. Nathan Zhang, founder of IVF USA, explains that by cultivating the embryo to the blastocyst stage (the 5th to 7th day of development), a more comprehensive observation of the embryo’s growth can be achieved. At this stage, the embryo primarily divides into two parts: one will develop into the fetus, and the other will form the placenta and umbilical cord.

Through IVF-PGT, embryologists take 3-5 cell samples from the part that will develop into the placenta for chromosomal and genetic analysis. This process screens for chromosomal abnormalities, enabling the selection of healthy embryos for transfer, which significantly reduces the risk of miscarriage and fetal arrest.

For older women, especially those over the age of 38, the quantity and quality of eggs decline with age, increasing the likelihood of chromosomal abnormalities in embryos. IVF-PGT technology, through precise genetic analysis, helps these women select healthy embryos, thereby improving success rates and increasing the chances of a successful pregnancy. This technology is undoubtedly a breakthrough option for women facing age-related fertility challenges.

Many patients may worry that taking a sample from the embryo could affect its development. In response, Dr. Nathan Zhang assures that in modern, advanced laboratories, embryologists use non-invasive methods to collect samples, which do not negatively impact embryo development. Therefore, IVF-PGT is a verified and extremely safe assisted reproductive technology.

However, Dr. Nathan Zhang also emphasizes that the success of IVF depends not only on the technology but also on the experience of the doctors and the quality of the laboratory. Differences in technology and equipment between clinics and labs may affect the outcome. Choosing an experienced doctor and a well-equipped, reputable clinic is a crucial step in ensuring IVF success.

At IVF USA, Dr. Nathan Zhang leads a team that provides personalized, scientifically tailored IVF plans for every patient. Our IVF-PGT technology not only helps older women select healthy embryos, but is also suitable for families with genetic risks or a history of recurrent miscarriages, ensuring a smoother IVF journey.

Currently, IVF USA offers egg freezing and IVF services in the USA, and has expanded its services beyond the United States to include IVF and egg freezing in Japan, Thailand, Mexico, Taiwan, and Hong Kong. We collaborate closely with IVF specialists worldwide. If you have any questions or need consultation regarding IVF, feel free to contact us. Dr. Nathan Zhang and his team are here to provide professional guidance to help you achieve your dream of a healthy pregnancy.